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Mass transfer coefﬁcientTargeted delivery of imaging agents to cells can be optimized with the understanding of uptake and efﬂux
rates. Cellular uptake of macromolecules is studied frequently with ﬂuorescent probes. We hypothesized
that the internalization and efﬂux of ﬂuorescently labeled macromolecules into and out of mammalian
cells could be quantiﬁed by confocal microscopy to determine the rate of uptake and efﬂux, from which
the mass transfer coefﬁcient is calculated. The cellular inﬂux and efﬂux of a third generation poly(amido
amine) (PAMAM) dendrimer labeled with an Alexa Fluor 555 dye was measured in Capan-1 pancreatic
cancer cells using confocal ﬂuorescence microscopy. The Capan-1 cells were also labeled with
5-chloromethylﬂuorescein diacetate (CMFDA) green cell tracker dye to delineate cellular boundaries. A
dilution curve of the ﬂuorescently labeled PAMAM dendrimer enabled quantiﬁcation of the concentration
of dendrimer in the cell. A simple mass transfer model described the uptake and efﬂux behavior of the
PAMAM dendrimer. The effective mass transfer coefﬁcient was found to be 0.054±0.043 μm/min, which
corresponds to a rate constant of 0.035±0.023 min−1 for uptake of the PAMAM dendrimer into the
Capan-1 cells. The effective mass transfer coefﬁcient was shown to predict the efﬂux behavior of the
PAMAM dendrimer from the cell if the fraction of labeled dendrimer undergoing non-speciﬁc binding is
accounted for. This work introduces a novel method to quantify the mass transfer behavior of ﬂuorescently
labeled macromolecules into mammalian cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The rate of transport of biological macromolecules into mammalian
cells is of signiﬁcant interest for drug delivery. Intensive investigations
have been directed toward developing novel methods to affect macro-
molecular transport into mammalian cells [1–6], but comparatively
little work has been done to quantitatively understand the time course
of uptake into or efﬂux frommammalian cells. Dendrimers are a class of
macromolecules applied widely as delivery vehicles for cellular inter-
nalization of biomolecules into cells [7]. For example, dendrimers
have been used as an antibacterial agent [8], as a transfection agent
for oligonucleotides [9–13], and a delivery vehicle for biologically active
molecules such as anti-arthritis drugs [14], corticosteroids [15], and
ibuprofen [16].
The uptake of dendrimers by mammalian cells is mostly limited to
a qualitative understanding, where the dendrimer's charge governs
its behavior [17,18]. The mechanism of internalization has been
studied through scanning electron microscopy [19] and ﬂuorescencel rights reserved.[20–23], showing that internalization occurs through endocytosis
[19,22,23], in particular adsorptive endocytosis [22]. The exact mech-
anism appears to depend on the surface charge of the PAMAM
dendrimer itself [24], where PAMAM dendrimers with an anionic sur-
face are internalized via caveolae-mediated endocytosis, while neu-
tral and cationic PAMAM dendrimers are taken up via non-clathrin,
non-caveolae-mediated endocytosis [23]. Other work appears to indi-
cate uptake through a cholesterol-dependent pinocytotic pathway in
the case of cationic dendrimers [20,21]. It has also been shown that
PAMAM dendrimers exhibit dose-dependent cytotoxicity [25,26],
most likely due to their ability to perforate lipid bilayers [27,28].
The exocytosis of dendrimers has only been studied over short dura-
tions of about an hour [20]. The surface charge of the dendrimer has
been shown to affect the rate of uptake, where uptake rate increases
from the neutral to anionic case, while the cationic dendrimers are
taken up fastest [23]. Semi-quantitative analysis of the uptake of an
intrinsically ﬂuorescent dendrimer by Caco-2 human colon adenocar-
cinoma cells showed that within 5 min the dendrimer was present in
the cytoplasm, and after 35 min it had reached the nucleus [29]. Only
one study has quantitatively investigated the binding of PAMAM
dendrimers to the surface of NA1B ﬁbroblast cells from the mouse,
Fig. 1. Reversed-phase HPLC chromatograph of Alexa Fluor 555-PAMAM G3, eluted
with a 20 minute linear gradient from 0 to 80% acetonitrile in aqueous 0.1%
triﬂuoroacetic acid, at 50 °C, monitored at 555 nm.
295A.W. Opitz et al. / Biochimica et Biophysica Acta 1828 (2013) 294–301and determined a dissociation constant of the dendrimer from the
cell surface [30].
Overall, many of the examples cite a more rapid uptake of a
dendrimer-complexed or conjugated active molecular agent over
the active molecule alone. Therefore, we quantitated the uptake rate
constant and mass transfer coefﬁcient of a third generation PAMAM
dendrimer ﬂuorescently labeled with an Alexa Fluor 555 dye as a
model system. Hence, this study generates an additional baseline
study of PAMAM dendrimers as a cellular transfection agent. More
importantly, we provide proof of concept for the novel use of confocal
ﬂuorescence microscopy for the quantitative measurement of cellular
uptake and efﬂux rates of ﬂuorescently labeled molecules. Further,
we develop a simple, lumped mass transfer model that is used to
extract the effective mass transfer coefﬁcients from the quantitative
uptake experiments and determination of the cell volume and surface
area. As the mass transfer coefﬁcient gives the fundamental rate of
transport of a species independent of the area available for transport,
these mass transfer coefﬁcients can be used in physiologically-based
pharmacokinetic models, e. g. [31]. Determining a mass transfer coef-
ﬁcient for a compound allows for a fundamental understanding of
how the compound is internalized. The method introduced here will
also be used to study the uptake of genetic imaging nanoparticles
used to visualize and quantitate oncogene mRNA expression in pan-
creatic cancer cells. [32–35].
2. Materials and methods
2.1. Preparation of Alexa Fluor 555-PAMAM G3
The Alexa Fluor 555-PAMAM G3 dendrimers were synthesized
following a protocol developed by Dr. Nariman Amirkhanov, adapted
from the “Alexa Fluor 555 protein labeling kit” instructions (Molecular
Probes) [36]. The third generation PAMAM (Sigma), bearing 32 primary
amines per dendrimer, was used as received at 20% w/v in methanol.
For the labeling reaction, 20 μL of the stock PAMAM G3 solution was
combined with 0.6 mg of Alexa Fluor 555 succinimide ester dissolved
in 60 μL of acetonitrile to achieve a molar ratio of one to one. Addition-
ally, 30 μL of 0.1 M sodium bicarbonate and 190 μL of deionized water
were added to the reaction mixture, yielding a ﬁnal pH of ~9. The reac-
tionwas allowed to proceed for 3 h. Stoichiometric amounts of PAMAM
G3 dendrimer and Alexa Fluor 555 succinimide ester were used, in
order to label an average of one primary amine on the surface of each
PAMAM dendrimer, out of 32 available amines. The product was
puriﬁed using a Centricon Centrifugal Filter Unit (Millipore) with a
3000 Dalton cutoff for 20 h at 2000×g. The absorption spectra of the
upper and lower fractions collected after ﬁltrationweremeasured, indi-
cating a molar ratio of Alexa Fluor 555-PAMAMdendrimer in the upper
fraction vs. free Alexa Fluor 555 in the lower fraction of 96:4. This result
was interpreted as a 96% yield of PAMAM dendrimer labeling. The
upper fraction was analyzed using reverse-phase HPLC with a linear
gradient from 0 to 80% acetonitrile in aqueous 0.1% triﬂuoroacetic
acid, at 50 °C, monitored at 555 nm, the absorption peak of the Alexa
Fluor 555 dye. The resulting chromatograph showed a single peak
(Fig. 1). Due to the hydrophobic nature of the Alexa Fluor 555 dye, the
labeled Alexa Fluor 555-PAMAMpeak can be expected to elute at higher
acetonitrile concentration than any unlabeled PAMAM dendrimer.
Unconjugated Alexa Fluor 555 eluted during the washing step at 100%
acetonitrile with 0.1% triﬂuoroacetic acid.
2.2. Cell culture
Human Capan-1 pancreatic cancer cells (ATCC) were maintained in
complete medium (RPMI 1640 with 20% fetal bovine serum and 1%
penicillin/streptomycin, Sigma Aldrich) at 37 °C under 5% CO2. The
cell line was chosen because the method described here will be used
to quantitate the uptake behavior of genetic imaging nanoparticlesinto pancreatic cancer cells [32–35]. The cells were grown to ~80%
conﬂuency in 75 cm2 ﬂasks (BD Biosciences) before plating them for
an experiment. The experiments were performed in Nunc Lab-Tek II
No. 1.5 chambered coverslips (Thermo Fisher Scientiﬁc) with eight
wells. The Nunc chambers were incubated with 0.01% 150–300 kDa
Poly-L-Lysine (Thermo Fisher Scientiﬁc) in sterile water for 12 h to in-
crease binding of the cells to the glass surface and to prevent aggrega-
tion of the PAMAM on the glass surface [37]. The chambers were then
washed with phosphate buffered saline (PBS) and deionized water,
and were allowed to dry for at least 24 h. before use. Approximately
3000 cells were plated in each 0.7 cm2well, approximately 24 h. before
an experiment. This number of cells was chosen to ensure that the cells
remained separate and did not form a conﬂuent monolayer or clusters.
The cells were allowed to attach to the slide for about 14 h prior to
CMFDA labeling below.
2.3. Green tracker dye labeling of cells
The cell surface and hence, internal volume, was deﬁned by label-
ing the cells in each well with 200 μL of 10 μM CellTracker™ Green
5-chloromethylﬂuorescein diacetate (CMFDA) (Invitrogen) in serum-
free medium containing 0.1% dimethylsulfoxide for 40 min, as
instructed by the manufacturer [38]. Following the incubation with
the dye was another 30 min of incubation in complete medium.
Following the second incubation, the cells were washed once with
PBS. After staining, the chambered coverslips were wrapped in alumi-
num foil to prevent photobleaching and incubated at 37 °C until the
experiment was started. The cytoplasmic ﬂuorescence within the cells
was used for analysis to determine the boundaries aswell as the surface
area and volume of the cell, as demonstrated previously [30]. CMFDA
labeling of the cells was completed 5–6 h prior to the start of each
PAMAM uptake experiment.
2.4. Fluorescent PAMAM uptake measurements
Alexa Fluor 555-PAMAM G3 uptake experiments were performed
with a Zeiss LSM 510 NLO on an Axiovert 200 M with a motorized
stage. Samples were maintained at 37 °C and 5% CO2 in a humid envi-
ronment using a PECON Environmental Incubation System along with
a PECON 22.5 mm Objective Heater. To visualize the samples a 20×
Plan-Apochromat (NA 0.75) lens was used. An Argon laser (25 mW)
at 488 nm and a HeNe laser (1 mW) at 543 nm were used to excite
the ﬂuorophores introduced into the samples, and a HeNe laser
(5 mW) at 633 nm was used to auto-focus the coverslip as a refer-
ence in reﬂection mode. The Argon and HeNe lasers were attenuated
via software control of the acousto-optic tunable ﬁlter to avoid light
Fig. 3. Final cell concentration as a function of bulk concentration.
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pinhole diameter was set to 114 μm for the green channel and
98 μm for the red channel. These settings were chosen to ensure
that the slice thickness (2.5 μm) was the same for both channels,
and images were taken at 2.5 μm z-intervals, and typically 12–15
slices per time point were taken to cover the height from the cover-
slip to above the cells to reconstruct the cell volume. Signal collection
from each ﬂuorophore was achieved with a 500–530 nm band pass
ﬁlter for the green channel and a 560 nm long pass ﬁlter for the red
channel. To reduce crosstalk between the channels, samples were
imaged in multi-track fast-line switch mode, which resulted in 1.7 s
scan time per slice of 1024×512 pixels.
The red channel intensity recorded in the cells as a function of
time was converted to concentration using a calibration curve of
intensity versus Alexa Fluor 555-PAMAM concentration (Fig. 2). The
dilution curve was obtained across a range from zero to 10 μM of
Alexa Fluor 555-PAMAM in complete medium without any cells
present. The intensity was measured using a running average with a
pixel size of 10 to smooth noise along a line randomly placed through
the image. The background intensity was 15.74±0.95 (ﬂuorescence
units), while the straight line ﬁt to the data showed a slope of
18.55±0.48 ﬂuorescence units/μM.
2.5. Alexa Fluor 555-PAMAM uptake and efﬂux experiments
After incubation at 37 °C for 15 min in the microscope without
illumination, a suitable cluster of cells, 3 to 7 cells in the ﬁeld of view
that were not in a cluster, was selected and an image z-series was
acquired. Next, the medium was removed and medium containing a
given concentration of Alexa Fluor 555-PAMAM G3 was pipetted into
thewell. The chamberwas coveredwith amicroscope slide tominimize
evaporation of the medium. During the ﬁrst hour, z-series data was
acquired at eight-minute intervals, followed by 36-minute intervals
for up to 3 h. The same procedure was followed for the efﬂux experi-
ments, except the cells started in equilibrium with medium containing
a given concentration of Alexa Fluor 555-PAMAM G3, which was
replaced with plain medium.
2.6. Image and data analysis
The images were analyzed using the program Volocity (Release
3.1, Improvision). The cells were identiﬁed by setting the green channel
threshold just above background intensity. Everything that was
highlighted using this qualiﬁer was deemed a cell and thus the volume
and surface area of each cell was identiﬁed. All red Alexa Fluor 555
ﬂuorescence inside the cell volume was considered to be Alexa Fluor
555-PAMAM present inside the cell. The average concentration ofFig. 2. Dilution curve of Alexa Fluor 555-PAMAM G3 in complete medium.Alexa Fluor 555-PAMAM inside the cell was calculated from the average
ﬂuorescencemeasured throughout each cell, using the calibration curve
in Fig. 2.
The uptake of the Alexa Fluor 555-PAMAM into the cells was
modeled as a ﬁrst order mass transfer process, which over time will
reach equilibrium (see Appendix 1 for derivation). The dendrimer
concentration inside the cell (CAII) is related to that in the buffer
(CA0I ) by:
CIIA tð Þ ¼
CIA0
M
1− exp − aKmM
VII
t
  
: ð1Þ
CA0
I is assumed to be constants as the reservoir is effectively
inﬁnite. Km is a mass transfer coefﬁcient that includes all processes
leading to cellular uptake and efﬂux, a is the cell surface area, and
VII is the volume of the cell. M is a distribution coefﬁcient deﬁned as
M=CA,eqI /CA,eqII , where M is determined at long times when the bulk
concentration and the concentration inside the cell are in equilibrium.
The same model with different integration limits (CIIA0 ¼ C
I
A0
.
M
, to
CA
I =0, which is the ﬁnal concentration in the reservoir at a value of
zero in the efﬂux case) predicts the following efﬂux behavior:
CIIA tð Þ ¼ CIIA0−CIIAb
 
exp −aKmM
VII
t
 
þ CIIAb ð2Þ
where CAbII is the concentration of dendrimer bound inside the cell.
The mass transfer coefﬁcient is related to the commonly used rate
constant, k, as shown in Eq. (3).
k ¼ Km M  a

VII ð3Þ
Note that the rate constant is not only proportional to the mass
transfer coefﬁcient (Km), but also includes the partition coefﬁcient
and ratio of cell area to volume. Through measurement of the cell
area, volume and the partition coefﬁcient, our method can isolate
the fundamental uptake behavior that describes the effective overall
process of cellular uptake. This can be used then, for example, in
physiologically-based pharmacokinetic (PBPK) models [31]. In a
typical PBPK model the various organs in the body are described by
two compartments, a vascular and an extravascular compartment.
The equation describing the extravascular compartment [39] has the
same form as Eq. (1) above, further underlying how the parameter
measured here can be used for PBPK modeling.
Fig. 4. Capan-1 cells right before (a) and 3 h after (b) the addition of 1.1 μM Alexa Fluor 555-PAMAM G3 dendrimer. Upper set of images shows visible and red channel, lower set
of images is maximum intensity projection of red channel only. Inset is the normalized intensity distribution of the red channel solution surrounding the cells, where the line
histogram in panel (b) is the intensity distribution at time zero (panel a). Scale bar indicates 20 μm.
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Some optical foreshortening will occur when recording the z-stack
through cells due to the different refractive indices between the air,
medium, cell and the glass coverslip making up the sample [40].
While distortions occur in the axial as well as the radial directions
of the laser beam, the axial distortions are typically muchmore severe
[40], and thus in this work only the non-linear geometrical correction
for axial distortions developed by van Elburg et al. [41] will be used.
The distortion in the z-axis can affect the surface area to volume
ratio; therefore a correction factor for the surface area to volume
ratio was calculated. The correction factor was determined by
applying van Elburg's focal shift to an ellipsoid of height 20 μm, and
a major and minor axis of 19 μm and 8 μm, respectively, with detailsFig. 5. Fit uptake behavior of Alexa Fluor 555-PAMAM G3, each bulk concentration is an
average of 5 cells. The error bars are a combination of theuncertainty from theﬂuorescence
measurements in the cells and the error from the dilution curve.given in Appendix 2. The correction factor is calculated from Eq. (4),
which gives a minimal correction of only Fz-axis=0.996.
Fz−axis ¼
A
V
,
Adistorted
Vdistorted
ð4Þ
Although the effects of z-axis distortion on the volume (40%) and
area (41%) are substantial, the ratio is largely unaffected. All surface
area to volume ratios reported henceforth have been corrected for
axial distortions using the correction factor, Fz-axis.
3. Results
The mass transfer model as derived assumes that the ﬁnal concen-
tration of the probe inside the cell is proportional to the concentra-
tion in the reservoir. This assumption is reasonable as the cells will
reach equilibrium with the reservoir outside the cell over time. This
is shown to be valid by plotting the cell (CAbII ) vs. bulk probe concen-
tration (CAI ) (Fig. 3), yielding a slope of 0.67±0.10. This indicates
that the dendrimer partitions favorably into the cell as compared to
the surrounding medium.
The red ﬂuorescence inside the Capan-1 cells due to the Alexa Fluor
555-PAMAM G3 dendrimer was converted to concentration using the
dilution curve shown in Fig. 2. An example image showing the cells as
well as the red ﬂuorescence of the Alexa Fluor 555-PAMAM before
and 3 h after the addition of 1.1 μM of Alexa Fluor 555-PAMAM is
shown in Fig. 4.Table 1
Cell and bulk concentration of Alexa Fluor 555-PAMAM G3.
Nominal CAI [μM] CAI [μM] CAbII [μM] M AV [μm−1]
0.4 0.41±0.12 0.63±0.20 0.66±0.28 1.13±0.06
0.6 0.64±0.18 1.00±0.27 0.64±0.25 0.56±0.02
0.9 0.87±0.23 1.37±0.41 0.63±0.25 1.04±0.07
1.1 1.08±0.29 1.43±0.48 0.76±0.32 1.88±0.14
CA
I—bulk concentration; CAbII —ﬁnal concentration inside cells; M—distribution coefﬁcient;
AV—surface area to volume ratio.
Table 2
Fit results for uptake of Alexa Fluor 555-PAMAM G3.
Nominal CAI [μM] k [min−1] k [h−1] Km [μm/min] Km [μm/h] r2
0.4 0.046±0.021 2.74±1.27 0.062±0.039 3.69±2.32 0.89
0.6 0.026±0.018 1.58±1.08 0.073±0.057 4.35±3.42 0.46
0.9 0.043±0.037 2.56±2.23 0.065±0.063 3.89±3.75 0.77
1.1 0.025±0.015 1.51±0.91 0.018±0.013 1.06±0.79 0.63
CA
I—bulk concentration; k—rate constant; Km—mass transfer coefﬁcient, r2—quality of ﬁt.
Fig. 6. Prediction of the efﬂux of Alexa Fluor 555-PAMAM G3 dendrimers from Capan-1
cells. The error bars at early times are similar to those seen for the uptake and have
thus been excluded for clarity. Each bulk concentration is an average of 5 cells. The
error bars are a combination of the uncertainty from the ﬂuorescence measurements
in the cells and the error from the dilution curve.
298 A.W. Opitz et al. / Biochimica et Biophysica Acta 1828 (2013) 294–301Four bulk concentrations were investigated, ranging from 0.4 to
1.1 μM. The concentration inside the cells was observed to rise rapidly
within the ﬁrst 30 to 50 min, and then followed by a monotonic
approach to a plateau. The resulting time course, along with a least
square ﬁt of the data to the linear form of Eq. (1), is shown in Fig. 5.
The error bars shown include both uncertainty propagated from the
dilution curve along with the intensity uncertainty from the cellular
intensity measurements. The ﬁt parameters are shown in Table 1,
while the resulting rate constants and mass transfer coefﬁcients are
shown in Table 2. From the ﬁts an average mass transfer coefﬁcient of
0.054±0.043 μm/min was obtained.
Using the protocol described above, the efﬂux of the labeled
dendrimer from the live cells was measured by confocal ﬂuorescence
imaging. The efﬂux data were predicted using the mass transfer coef-
ﬁcient obtained from the uptake experiments, which is possible
because we independently measured the cell area and volume during
the efﬂux experiments. The only ﬁt parameter is the amount of
dendrimer that undergoes non-speciﬁc binding in the cell. The aver-
age fraction of Alexa Fluor 555-PAMAM G3 present in the cells at
the end of the experiment was 0.67±0.43. The parameters necessary
to predict the efﬂux proﬁle of the Alexa Fluor 555-PAMAM are shown
in Table 3. The efﬂux data, as shown in Fig. 6, exhibited a quick drop
within the ﬁrst 30 min and then leveled out to a steady plateau
value. Sample images showing the cells as well as the red ﬂuores-
cence of the Alexa Fluor 555-PAMAM before and 3 h after the remov-
al of 0.9 μM of Alexa Fluor 555-PAMAM are shown in Fig. 7.4. Discussion
The protocol for quantitative measurement of the rate of cellular
uptake and efﬂux is demonstrated to give consistent results across a
range of dendrimer concentrations. Using a simple, lumped mass
transfer model, the effective rate of mass transfer, Km, for uptake
was also found to describe the subsequent efﬂux. All previous studies
of cellular uptake of a compound reported rate constants, without
reduction to the more fundamental mass transfer coefﬁcient. To put
the rate constants obtained by our method in perspective, the rate
constants for the uptake of a variety of biologically active molecules,
along with the rate constant calculated in this work, are compared
in Table 4. Comparing the average rate constant obtained for the
Alexa Fluor 555-PAMAM G3 dendrimer, 0.035 min−1, to molecules
taken up commonly by cells in vitro, the results obtained here are
comparable to those for other compounds taken up by endocytosis.Table 3
Parameters used to predict the Alexa Fluor 555-PAMAM G3 efﬂux behavior.
Nominal
CA
I [μM]
CA0
II
[μM]
CAb
II
[μM]
Km,uptake
[μm/min]
AVrelease
[μm−1]
Fraction
remaining
r2
0.4 1.37±0.75 0.87±0.43 0.062±0.039 2.52±0.16 0.64±0.47 0.70
0.6 1.42±0.69 0.89±0.30 0.073±0.057 0.74±0.11 0.62±0.37 0.84
0.9 2.17±0.87 1.62±0.68 0.065±0.063 2.40±0.18 0.75±0.43 0.82
1.1 2.72±1.47 1.86±0.71 0.018±0.013 0.99±0.15 0.68±0.45 0.55
CA
I—bulk concentration; CA0II —initial concentration inside cells; CAbII —ﬁnal concentration
inside cells; Km,uptake—mass transfer coefﬁcient; AVrelease—surface area to volume ratio,
r2—quality of ﬁt.It should be noted in particular that antibodies and the IGF-1 peptide
hormone are internalized by the cell through receptor-mediated
endocytosis. While it is not known to which cell surface macromole-
cule Alexa Fluor 555-PAMAM binds in order to be internalized, it is
known that the cell carries a negative charge, while the Alexa Fluor
555-PAMAM at approximately neutral pH is positively charged. This
promotes attachment of the Alexa Fluor 555-PAMAM to the cell sur-
face. Earlier studies discovered that the PAMAM dendrimer is taken up
via endocytosis and accumulates in multivesicular bodies [19,20,22,23],
which is consistent with our results.
Though no full kinetic or mass transfer analysis has been reported
previously for PAMAM dendrimers, there have been studies that
have recorded the accumulation of ﬂuorescently labeled PAMAM G4
dendrimers carrying a steroid [15], ibuprofen [16], or ﬂuorescent label
[23] into mammalian cells. In each case, relatively rapid uptake occurred
within the ﬁrst 30 to 50 min, which was then followed by a slower
increase, reaching a plateau. That behavior is comparable to the uptake
curves measured in this work. The uptake of an intrinsically ﬂuorescent
dendrimer into mammalian cells has also been reported [29]. Although
the time sequence of the uptake was not reported, the authors noted
that after 5 min the dendrimer was present in the cytoplasm, and after
35 min the dendrimer had reached thenucleus, indicating that it had dif-
fused throughout most of the cell. This agrees roughly with the time
course seen in the uptake data from this work.
The model parameters obtained from the uptake experiment were
able to represent the efﬂux data, although a considerable fraction was
observed to be immobilized. This is most likely due to nonspeciﬁc
binding inside the cells resulting from the high number of positively
charged amines on the unmodiﬁed end groups of the dendrimer. Also,
it has been shown that ﬂuorescent dyes can bind non-speciﬁcally to
cells [47,48]. In efﬂux experiments of Oregon green-PAMAMdendrimers
from murine melanoma cells, no efﬂux was recorded, which might
indicate a difference in how different cell types internalize and efﬂux
PAMAM dendrimers [20].
It should be noted, however, that the long duration of the uptake
and efﬂux experiments can adversely affect the cells. Upon introducing
fresh medium to observe the dendrimer efﬂux, not all the cells
remained attached to the coverslip, which may indicate that those
cells were not healthy anymore. Great care was taken to select healthy
cells for the efﬂux experiments, which were chosen by visual inspec-
tion. While dead cells, indicated by very high Alexa Fluor 555-PAMAM
concentration inside the cell (CAbII >10μM), were excluded from the
analysis, some cell damage due to the primary amines of the PAMAM
Fig. 7. Capan-1 cells right before (a) and 3 h after (b) removing the 0.9 μM bulk solution of Alexa Fluor 555-PAMAM G3 dendrimer. Upper set of images shows visible and red
channel, lower set of images is maximum intensity projection of red channel only. Inset is the normalized intensity distribution of the red channel solution surrounding the
cells, where the line histogram in panel (b) is the intensity distribution at time zero (panel a). Scale bar indicates 20 μm.
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[22,26,27]. Phototoxicity due to light from the mercury arc lamp used
to select a cluster of cells for the efﬂux experiment, combined with the
reported cytotoxicity of amine-terminated PAMAM dendrimers [22,26],
cannot be ruled out. Commercially available live/dead dyes were not
used in order to avoid interference from the live/dead dye with the
CMFDA and Alexa Fluor 555 dye signals used to quantify the uptake
behavior. While the potential for cell death needs to be considered, the
consistency of the data shown in Figs. 5 and 6 suggests that any cell
wall damage did not lead to non-speciﬁc uptake or efﬂux, as the overall
behavior was captured with the mass transfer model. Additionally, the
well-documented interaction between PAMAM dendrimers [22,26,27]
and mammalian cells, and the resulting disruption of the cell wall,
would be observed to some degree in all uptake experiments of this
nature. Therefore these effects are part of the uptake or efﬂux behaviorTable 4
Rate constants of uptake of different molecules into cells.
Author Agent Cell type Cancer type [min−1]
Shih [42] LL2 (Mab) Raji Burkitt lymphoma 0.1050
Shih [43] RS7 (Mab) MDA-MB-468 Breast 0.0147
Stein [44] RS7 (Mab) Calu-3 Lung 0.0232
Paye [45] IGF-1 BAEC NA 0.0760
Gupta [46] Glucose β-cells NA 2.6900
This work PAMAM Capan-1 Pancreatic 0.0350of PAMAMdendrimers, and not a shortcoming of themethod introduced
here.
5. Conclusions
A method for quantitatively studying the uptake of ﬂuorescently
labeled macromolecules into mammalian cells was developed and
demonstrated to determine the rate of uptake and efﬂux of ﬂuores-
cently labeled Alexa Fluor 555-PAMAM G3. A simple mass transfer
model was able to describe the overall observed behavior. The
dendrimer was found to partition preferentially into the cells (M=
0.67±0.10) with a mass transfer coefﬁcient of 0.054±0.043 μm/min.
The corresponding effective rate constant is comparable to previous
studies of other biologically active compounds that enter cells by endo-
cytosis. While the results shown here are only applicable to the partic-
ular cell line and dendrimer studied here, the technique introduced
with these results holds great promise for quantitative study of in
vitro uptake and efﬂux behavior of ﬂuorescently labeled macromole-
cules in mammalian cells.
The protocol established here has advantages over other techniques
currently used. Most importantly, the concentration of a compound can
be studied over time in the same cluster of cells, while knowing the
exact number of cells being investigated. Furthermore, the surface
area and volume of each cell can be determined, which enables deter-
mination of the effectivemass transfer coefﬁcient. This is a more funda-
mental measure of the effective rate of cellular transfection that could
300 A.W. Opitz et al. / Biochimica et Biophysica Acta 1828 (2013) 294–301potentially be used in PBPK models [49]. The mass transfer model used
here draws close parallels to the equations typically used to describe the
behavior of organs in PBPK models. Therefore the method described
here can potentially be used to measure parameters for a PBPK model
in vitro before having to do a full tissue distribution study.
A limitation with using high laser intensity for increased signal is
photobleaching and even cell death. Naturally, reducing laser light in-
tensity for ﬂuorophore excitation will result in a lower signal-to-noise
ratio. Noise can be reduced by decreasing the scan speed or increased
averaging, yet the total scan time is limited by the need to capture the
uptake and efﬂux kinetics. For this technique to be applied successful-
ly, the scan time for the necessary number of z-slices through the
sample should be two orders of magnitude shorter than the actual
time of uptake. As shown here, this is necessary to ensure that the
initial rise in concentration inside the cell is accurately captured.
This guideline can be relaxed if a fast scanning confocal microscope
is available (i.e., line scanning or spinning disk).
Overall, this work has demonstrated a novel technique to study
the uptake of ﬂuorescently labeled macromolecules into mammalian
cells. This will prove to be useful in the study of our genetic imaging
nanoparticles, as they have been shown to be effective using MRI
[50], PET [33], and SPECT [51] imaging techniques, while current
work is investigating ﬂuorescent labels [52]. The technique discussed
in this work will be used next to study the behavior of genetic imaging
nanoparticles with cancer cells in vitro.
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